Provision and RaySearch partner on RayStation proton therapy training


Provision and RaySearch partner on RayStation proton therapy training

KNOXVILLE, Tenn. (Oct. 18, 2015)—ASTRO Booth #250—Provision Healthcare is partnering with leading treatment planning software developer, RaySearch Laboratories AB, to offer new user education at the Provison Center for Proton Therapy’s state-of-the-art treatment and training facilities.

Provision was the first proton therapy center to adopt the company’s system, called RayStation, and has worked collaboratively with RaySearch since the launch of the Provision Center for Proton Therapy in January 2014.

“Over the past nearly two years, we have put RayStation through its paces, and we are pleased with the results. The physicists and medical dosimetrists who come for training will have a chance to learn from our clinical staff and see RayStation in action at a working medical center,” said Niek Schreuder, chief medical physicist for Provision Center for Proton Therapy. “Our world-class proton therapy facility plus a modern, fully-equipped training center will provide both classroom and hands-on instruction for the staff who will be working with patients and physicians in treatment planning.”

Trainers from Provision and RaySearch will conduct five-day training sessions, starting in January 2016, in both basic and advanced proton therapy planning.

“Although RaySearch provides planning training for our customers in our training center in New York, having a clinical site that can provide the entire spectrum of knowledge and experience is very valuable – especially a site like Provision that has been so successful in their implementation,” said Marc Mlyn, President of RaySearch Americas, the American subsidiary of RaySearch Laboratories AB.  “We are pleased to partner with the Knoxville team to offer such a high level of training.”

Because proton therapy is applied so precisely to a tumor, careful planning is essential to ensure the protons hit their target and to minimize damage of non-cancerous surrounding tissue. RayStation allows for detailed planning, while accounting for potential changes and needed adjustments over the weeks a patient undergoes treatment. Provision has experience in treating a range of tumor types and disease sites and will provide instruction in patient data management, patient modeling, planning and optimization, automated planning techniques and adaptive planning.

About Provision Healthcare
Provision Healthcare is a comprehensive healthcare group in the United States integrating clinical services, R&D, manufacturing, investment and a charitable foundation.  With an emphasis in cancer, Provision Healthcare is committed to providing cutting edge treatment, early detection and personalized care for cancer patients around the world.

About Provision Center for Proton Therapy
Provision Center for Proton Therapy is the first cancer treatment center of its kind in Tennessee and only the third in the Southeastern United States.  Open to all credentialed physicians and health systems in the region, the Provision Center for Proton Therapy has three treatment rooms and is able to treat up to 900 cancer patients annually. The center utilizes intensity modulated pencil beam scanning, the most accurate proton beam therapy in the world. This advanced cancer treatment capability is available in only a handful of cities. Provision Center for Proton Therapy is one of only 17 proton therapy centers in the nation and 50 in the world.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies. RaySearch’s software solutions are used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.